Chinese vaccine makers are caught in a steep downturn as intensifying competition pushes prices lower and erodes their profits. https://www.japantimes.co.jp/business/2025/12/02/companies/china-flu-shots-vaccine-makers/?utm_medium=Social&utm_source=mastodon #business #companies #pharmaceuticals #china #drugmakers #covid19vaccines #vaccinations
The U.S. faces a growing national security risk due to heavy dependence on China for key pharmaceutical ingredients, prompting calls to diversify supply chains to reduce vulnerability to geopolitical or health crises. https://www.japantimes.co.jp/commentary/2025/11/30/world/china-global-pharmaceuticals-card/?utm_medium=Social&utm_source=mastodon #commentary #worldnews #china #drugs #medicine #supplychains #us #pharmaceuticals
Japan will soon begin full-fledged discussions on revising medical service fees as inflation hits profits of clinics and hospitals. https://www.japantimes.co.jp/news/2025/11/29/japan/science-health/medical-service-fees-discussion/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #health #pharmaceuticals #japanmedicalassociation #medicine #financeministry
Scientists are still asking if GLP-1 drugs should be tested to prevent Alzheimer's in people at risk. https://www.japantimes.co.jp/business/2025/11/26/companies/novo-nordisk-glp-1-alzheimers/?utm_medium=Social&utm_source=mastodon #business #companies #novonordisk #alzheimer039s #pharmaceuticals
Indian officials are investigating whether safety lapses in the supply of a pharmaceutical ingredient were responsible for contaminating cough syrup that has killed at least 24 children. https://www.japantimes.co.jp/news/2025/11/24/asia-pacific/crime-legal/indian-probe-children-cough-syrup/?utm_medium=Social&utm_source=mastodon #asiapacific #crimelegal #india #pharmaceuticals
The LDP and the Japan Innovation Party have agreed to reach an early conclusion on a proposed hike in patients’ out-of-pocket expenses for prescription medicines similar to over-the-counter drugs. https://www.japantimes.co.jp/news/2025/11/13/japan/ldp-jip-otc-drugs/?utm_medium=Social&utm_source=mastodon #japan #ldp #nipponishinnokai #medicine #health #nationalhealthcare #pharmaceuticals
Longevity labs, “immortality islands” and grapeseed pills are part of China’s national project to conquer aging, despite sometimes shaky science and extravagant claims. https://www.japantimes.co.jp/news/2025/11/09/asia-pacific/science-health/china-longevity-aging/?utm_medium=Social&utm_source=mastodon #asiapacific #sciencehealth #aging #health #china #medicine #pharmaceuticals
As Japan grapples with a record number of fatal bear attacks, a small company in Tokushima Prefecture has developed a new bear repellent spray — a rare domestic product in a market dominated by imported options. https://www.japantimes.co.jp/news/2025/11/04/japan/japan-bear-spray/?utm_medium=Social&utm_source=mastodon #japan #bears #animals #pharmaceuticals
Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations
The health ministry has started considering ways to promote the use of follow-on products of very expensive original biological drugs. https://www.japantimes.co.jp/news/2025/10/26/japan/science-health/follow-on-biologics/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #medicine #mhlw #pharmaceuticals
Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company's biggest challenge: how to better tap into America's mass market for weight-loss drugs. https://www.japantimes.co.jp/business/2025/10/22/companies/novo-nordisk-board-us-consumers/?utm_medium=Social&utm_source=mastodon #business #companies #wegovy #pharmaceuticals #novonordisk
AstraZeneca's deal with U.S. President Donald Trump to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to November last year, sources have said. https://www.japantimes.co.jp/business/2025/10/14/companies/astrazeneca-medicine-deal-trump/?utm_medium=Social&utm_source=mastodon #business #companies #astrazeneca #pharmaceuticals #us #donaldtrump #trade #tariffs #republicans
AstraZeneca and Daiichi Sankyo’s drug Datroway has significantly improved survival and delayed the progression of breast cancer in patients with a particularly hard to treat form of the disease, AstraZeneca has said. https://www.japantimes.co.jp/business/2025/10/07/companies/astrazeneca-breast-cancer/?utm_medium=Social&utm_source=mastodon #business #companies #astrazeneca #daiichisankyo #health #cancer #medicine #pharmaceuticals
The planned interventions in the American economy reverse decades of hands-off approach to private enterprise. https://www.japantimes.co.jp/business/2025/10/05/trump-white-house-deals-midterms/?utm_medium=Social&utm_source=mastodon #business #us #donaldtrump #pharmaceuticals #medicine #ai #mining #energy
U.S. President Donald Trump’s new tariffs on pharmaceutical imports will not apply to countries with negotiated agreements with the U.S. that contain provisions on drugs, according to a White House official. https://www.japantimes.co.jp/business/2025/09/27/economy/pharmaceutical-tariffs-wont-apply-japan/?utm_medium=Social&utm_source=mastodon #business #economy #tariffs #donaldtrump #trade #pharmaceuticals #us #japaneseeconomy #usjapanrelations
A twice-a-year injection, recently approved for HIV prevention in the U.S. and the European Union, helps solve the problem of adherence, Gilead argues. https://www.japantimes.co.jp/business/2025/09/22/companies/gilead-twice-a-year/?utm_medium=Social&utm_source=mastodon #business #companies #hiv #medicine #gilead #pharmaceuticals #nationalhealthcare
Trump administration officials plan to link the active ingredient in Tylenol to autism Monday, The Washington Post reported, citing unnamed people familiar with the matter. https://www.japantimes.co.jp/news/2025/09/22/world/politics/trump-link-tylenol-autism/?utm_medium=Social&utm_source=mastodon #worldnews #politics #tylenol #autism #pharmaceuticals #us #donaldtrump #health #medicine
Senators Demand Names of Foreign Drugmakers Skirting FDA Import Bans
---
Citing a recent ProPublica investigation, Rick Scott, R-Fla., and Kirsten Gillibrand, D-N.Y., said they had “urgent concerns” about the agency’s oversight of foreign drugmakers and whether medications coming into the U.S. are safe.
https://www.propublica.org/article/senators-letter-fda-drug-import-bans?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
In fast-aging Japan, struggles with dementia are a common story. But researchers hope that future breakthroughs will help them rewrite the ending. https://www.japantimes.co.jp/news/2025/09/17/japan/science-health/dementia-research/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab
Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep